Edgewise Therapeutics, Inc.EWTXNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-book ratio
Latest
5.37
↑ 127% above average
Average (5y)
-20.02
Historical baseline
Range
High:5.37
Low:-87.61
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 5.37 | +145.7% |
| 2023 | 2.19 | +58.2% |
| 2022 | 1.38 | -49.9% |
| 2021 | 2.76 | +106.2% |
| 2020 | -44.18 | +49.6% |
| 2019 | -87.61 | - |